BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21368580)

  • 21. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
    Zheng C; Yinghao S; Li J
    Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
    Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X
    Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.
    Hurley PJ; Marchionni L; Simons BW; Ross AE; Peskoe SB; Miller RM; Erho N; Vergara IA; Ghadessi M; Huang Z; Gurel B; Park BH; Davicioni E; Jenkins RB; Platz EA; Berman DM; Schaeffer EM
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14977-82. PubMed ID: 22927397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
    Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
    FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
    Nishikawa R; Goto Y; Sakamoto S; Chiyomaru T; Enokida H; Kojima S; Kinoshita T; Yamamoto N; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2014 Jul; 105(7):802-11. PubMed ID: 24815849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.
    Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL
    Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
    Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
    J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.
    Tao J; Wu D; Xu B; Qian W; Li P; Lu Q; Yin C; Zhang W
    Oncol Rep; 2012 Jun; 27(6):1967-75. PubMed ID: 22407299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
    Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
    J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10.
    Chen Y; Zhang J; Wang H; Zhao J; Xu C; Du Y; Luo X; Zheng F; Liu R; Zhang H; Ma D
    BMC Cancer; 2012 Mar; 12():111. PubMed ID: 22439757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.
    Cao P; Deng Z; Wan M; Huang W; Cramer SD; Xu J; Lei M; Sui G
    Mol Cancer; 2010 May; 9():108. PubMed ID: 20478051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-200b inhibits prostate cancer EMT, growth and metastasis.
    Williams LV; Veliceasa D; Vinokour E; Volpert OV
    PLoS One; 2013; 8(12):e83991. PubMed ID: 24391862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
    Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
    J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer.
    Xiong SW; Lin TX; Xu KW; Dong W; Ling XH; Jiang FN; Chen G; Zhong WD; Huang J
    Pathol Oncol Res; 2013 Jul; 19(3):529-37. PubMed ID: 23456549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.
    Xiong H; Chen R; Liu S; Lin Q; Chen H; Jiang Q
    J Cell Biochem; 2018 Nov; 119(10):8123-8137. PubMed ID: 29923214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
    Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224.
    Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
    Tumour Biol; 2014 Oct; 35(10):10095-103. PubMed ID: 25017365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.